Will authorised biologics deter biosimilars? Utilising JFTC’s expertise in drug pricing Life Sciences IP Review, 08 Mar 2022 Issue: Report of the Japan Biosimilar Association On May 16, 2017, the Japan Biosimilar Association submitted a report titled “Th…